LINCOLN PHARMACEUTICALS LTD.
BSE: 531633
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 191.35+7.9% | 177.28-5.3% | 187.28+12.6% | 166.32+1.8% | 163.36+6.0% | 154.07-8.4% | 168.18+14.8% | 146.55 |
| Other Income | 9.53-60.7% | 24.26+678.4% | -4.20-127.7% | 15.15+109.4% | 7.23-52.6% | 15.27+322.0% | -6.88-176.7% | 8.97 |
| Total Income | 200.88-0.3% | 201.55+10.1% | 183.08+0.9% | 181.47+6.4% | 170.60+0.7% | 169.34+5.0% | 161.30+3.7% | 155.52 |
| EXPENSES | ||||||||
| Expenditure | 171.86+11.6% | 153.99-7.4% | 166.38+13.4% | 146.75+3.5% | 141.79+5.8% | 133.95-7.7% | 145.06+14.4% | 126.84 |
| Tax | 8.59-24.1% | 11.32+123.3% | 5.07-17.2% | 6.12-30.6% | 8.83+14.4% | 7.71+65.1% | 4.67-41.0% | 7.91 |
| PROFIT | ||||||||
| PBT | 29.02-39.0% | 47.55+184.7% | 16.70-51.9% | 34.72+20.5% | 28.81-18.6% | 35.39+117.8% | 16.25-43.4% | 28.68 |
| Net Profit | 20.43-43.6% | 36.23+211.4% | 11.63-59.3% | 28.60+43.1% | 19.98-27.8% | 27.68+139.1% | 11.57-44.3% | 20.77 |
| KEY METRICS | ||||||||
| OPM % | 12.38%-3.09pp | 15.47%+2.20pp | 13.27%-0.92pp | 14.19%-1.38pp | 15.57%+0.12pp | 15.45%-0.44pp | 15.89%+5.14pp | 10.75% |
| NPM % | 10.17%-7.81pp | 17.98%+11.63pp | 6.35%-9.41pp | 15.76%+4.05pp | 11.71%-4.63pp | 16.34%+9.16pp | 7.18%-6.17pp | 13.35% |
| EPS | 10.20-43.6% | 18.09+211.4% | 5.81-59.3% | 14.28+43.1% | 9.98-27.8% | 13.82+139.1% | 5.78-44.3% | 10.37 |
Corporate Events
Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗Board Meeting
The 32nd Annual General Meeting of the Company is scheduled …
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
Consider and approve unaudited Financial Results
BSE Filing ↗Board Meeting
considering and approving un-audited financial results, any …
BSE Filing ↗Board Meeting
considering and approving unaudited financial results, any o…
BSE Filing ↗Board Meeting
Consider and approve the audited (standalone and consolidate…
BSE Filing ↗Board Meeting
Consider and approve unaudited Financial Results
BSE Filing ↗Board Meeting
Consider and approve un-audited financial results (standalon…
BSE Filing ↗Board Meeting
Consider and approve Audited (standalone and consolidated) f…
BSE Filing ↗Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗